Urokinase-type plasminogen activator receptor (uPAR) assessed by liquid biopsies and PET/CT for prognostication in head and neck cancer patients.

Sci Rep · 2022 · PMC9645757 · PMID 36352036

Europe PMC DOI

hedged sentences

0.0440

closest p · 0.9× alpha

0.1310

boldest claim

The sentences

borderline significantp = 0.044actually significant

Pretreatment, high TNM Stage (S3–4) was borderline significant predictive of RFS (HR = 3.089 (95% CI 1.032–9.247), p = 0.044), whereas p16 status significantly predicted OS (HR = 4.257 (05% CI 1.128–16.064), p = 0.033), Table 3 .

also in 11,409 other papers

showed a trendp = 0.131not close (p > 0.1)

Although non-significant (NS), patients with incongruent results (one low/one high, n = 10) showed a trend of having a favorable prognosis compared to patients with high results from both modalities (log-rank p = 0.131), but inferior compared to patients with low uPAR-estimates on both modalities (p = 0.136).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.